230 related articles for article (PubMed ID: 15901526)
1. Persistent tumor-induced osteomalacia confirmed by elevated postoperative levels of serum fibroblast growth factor-23 and 5-year follow-up of bone density changes.
Zimering MB; Caldarella FA; White KE; Econs MJ
Endocr Pract; 2005; 11(2):108-14. PubMed ID: 15901526
[TBL] [Abstract][Full Text] [Related]
2. Tumor-induced osteomalacia. Kinetics of calcium, phosphorus, and vitamin D metabolism and characteristics of bone histomorphometry.
Siris ES; Clemens TL; Dempster DW; Shane E; Segre GV; Lindsay R; Bilezikian JP
Am J Med; 1987 Feb; 82(2):307-12. PubMed ID: 3812526
[TBL] [Abstract][Full Text] [Related]
3. Clinical and bone density outcomes of tumor-induced osteomalacia after treatment.
Umphrey LG; Whitaker MD; Bosch EP; Cook CB
Endocr Pract; 2007 Sep; 13(5):458-62. PubMed ID: 17872346
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and immunohistopathologic study of phosphaturic mesenchymal tumor].
Li DM; Wu HW; Li JD; Xia WB; Jiang Y; Zhong DR
Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):427-431. PubMed ID: 29886586
[No Abstract] [Full Text] [Related]
5. Hypercalcemic hyperparathyroidism complicating oncogenic osteomalacia. Effect of successful tumor resection on mineral homeostasis.
Reid IR; Teitelbaum SL; Dusso A; Whyte MP
Am J Med; 1987 Aug; 83(2):350-4. PubMed ID: 3303928
[TBL] [Abstract][Full Text] [Related]
6. Successful CT guided cryoablation of phosphaturic mesenchymal tumor in the soft tissues causing tumor-induced osteomalacia: a case report.
Cowan S; Lozano-Calderon SA; Uppot RN; Sajed D; Huang AJ
Skeletal Radiol; 2017 Feb; 46(2):273-277. PubMed ID: 27921126
[TBL] [Abstract][Full Text] [Related]
7. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.
Hu FK; Yuan F; Jiang CY; Lv DW; Mao BB; Zhang Q; Yuan ZQ; Wang Y
Chin J Cancer; 2011 Nov; 30(11):794-804. PubMed ID: 22035861
[TBL] [Abstract][Full Text] [Related]
8. A paranasal tumor associated with tumor-induced osteomalacia.
Inokuchi G; Tanimoto H; Ishida H; Sugimoto T; Yamauchi M; Miyauchi A; Nibu K
Laryngoscope; 2006 Oct; 116(10):1930-3. PubMed ID: 17003734
[TBL] [Abstract][Full Text] [Related]
9. Tumor-induced osteomalacia: a case report.
Romualdo-Silva DD; Silva BC; Caetano CV; Tibúrcio AM; Nunes MB; Chagas SA; Polito ET; Ferreira AR; Purisch S
Arq Bras Endocrinol Metabol; 2009 Apr; 53(3):378-82. PubMed ID: 19578602
[TBL] [Abstract][Full Text] [Related]
10. [Detection of the primary tumor site in tumor-induced osteomalacia by indium-111 octreotide scintigraphy: a case report].
Takahashi M; Toru S; Ota K; Izumiyama H; Yokota T; Mizusawa H
Rinsho Shinkeigaku; 2008 Feb; 48(2):120-4. PubMed ID: 18326305
[TBL] [Abstract][Full Text] [Related]
11. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature.
Folpe AL; Fanburg-Smith JC; Billings SD; Bisceglia M; Bertoni F; Cho JY; Econs MJ; Inwards CY; Jan de Beur SM; Mentzel T; Montgomery E; Michal M; Miettinen M; Mills SE; Reith JD; O'Connell JX; Rosenberg AE; Rubin BP; Sweet DE; Vinh TN; Wold LE; Wehrli BM; White KE; Zaino RJ; Weiss SW
Am J Surg Pathol; 2004 Jan; 28(1):1-30. PubMed ID: 14707860
[TBL] [Abstract][Full Text] [Related]
12. [Tumor-induced osteomalacia caused by a late-revealing phosphaturic mesenchymal tumor].
Chazal T; Khanine V; Lidove O; Godot S; Ziza JM
Rev Med Interne; 2017 Jun; 38(6):412-415. PubMed ID: 27659744
[TBL] [Abstract][Full Text] [Related]
13. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
[TBL] [Abstract][Full Text] [Related]
14. Determination of the elimination half-life of fibroblast growth factor-23.
Khosravi A; Cutler CM; Kelly MH; Chang R; Royal RE; Sherry RM; Wodajo FM; Fedarko NS; Collins MT
J Clin Endocrinol Metab; 2007 Jun; 92(6):2374-7. PubMed ID: 17374707
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of tumor-induced osteomalacia causing by phosphaturic mesenchymal tumor of the foot.
Liu S; Zhou X; Song A; Huo Z; Wang Y; Xia W; Liu Y
Medicine (Baltimore); 2019 Jul; 98(27):e16296. PubMed ID: 31277164
[TBL] [Abstract][Full Text] [Related]
16. Development of tumor-induced osteomalacia in a subcutaneous tumor, defined by venous blood sampling of fibroblast growth factor-23.
Ogura E; Kageyama K; Fukumoto S; Yagihashi N; Fukuda Y; Kikuchi T; Masuda M; Suda T
Intern Med; 2008; 47(7):637-41. PubMed ID: 18379151
[TBL] [Abstract][Full Text] [Related]
17. Intracranial phosphaturic mesenchymal tumors. A case report and review of literature.
Kojima D; Ohba S; Abe M; Suzuki A; Horibe S; Tateya I; Hasegawa M; Hirose Y
Neuropathology; 2022 Oct; 42(5):453-458. PubMed ID: 35880350
[TBL] [Abstract][Full Text] [Related]
18. Ethmoid tumor and oncogenic osteomalacia: Case report and review of the literature.
Villepelet A; Casiraghi O; Temam S; Moya-Plana A
Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Oct; 135(5):365-369. PubMed ID: 30026073
[TBL] [Abstract][Full Text] [Related]
19. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.
Mori Y; Ogasawara T; Motoi T; Shimizu Y; Chikazu D; Tamura K; Fukumoto S; Takato T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e57-63. PubMed ID: 20219587
[TBL] [Abstract][Full Text] [Related]
20. Pathologic quiz case. A 36-year-old woman with muscle pain and weakness. Phosphaturic mesenchymal tumor (mixed connective tissue variant)/oncogenic osteomalacia.
Reis-Filho JS; Paiva ME; Lopes JM
Arch Pathol Lab Med; 2002 Oct; 126(10):1245-6. PubMed ID: 12385334
[No Abstract] [Full Text] [Related]
[Next] [New Search]
